Search
for
Sort by
Research 31–60 of 84
- Adverse event reporting of four anti-Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: a real-world study based on the FDA adverse event reporting system
- Role of Polyphenols in Dermatological Diseases: Exploring Pharmacotherapeutic Mechanisms and Clinical Implications
- Light exposure and its applications in human health
- Phytochemistry, pharmacological activity, and potential health benefits of Glycyrrhiza glabra
- Three orphans one should know: red scalp, red ear and red scrotum syndrome
- Trichodynia: An Update on Definition, Etiopathogenesis, Diagnosis, and Treatment
- Occipital Neuralgia after Hair Transplantation and Its Treatment
- Hair Transplantation in Migraine Headache Patients
- Determination of adulteration in hair serums by LC-HRMS §
- The Rotterdam Study: 2018 update on objectives, design and main results
- Recent advances in microneedle composites for biomedical applications: Advanced drug delivery technologies
- HRT for women with premature ovarian insufficiency: a comprehensive review
- The nocebo effect: A clinicians guide
- Indications for Peripheral and Central Sensitization in Patients With Chronic Scalp Pain (Trichodynia)
- Microneedles as a perspective for transdermal therapeutic systems
- AS FINALIDADES TERAPÊUTICAS DA TOXINA BOTULÍNICA TIPO A
- The Effect of Botulinum Toxin on Hair Follicle Cell Regeneration Under Continuous Stress Conditions: a Pilot Animal Study
- Poliosis circumscripta: Overview and underlying causes
- Clinical and Molecular Genetic Findings of Cerebral Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
- Parry–Romberg Syndrome: Radioclinical Dissociation in a Paucisymptomatic Form and a Proposed Diagnostic Framework
- ZALCITABINE
- Toxicology and pharmacology of botulinum and tetanus neurotoxins: an update
- Emerging Roles for Ion Channels in Ovarian Cancer: Pathomechanisms and Pharmacological Treatment
- Systemic Lupus Erythematosus: Symptoms and Signs at Initial Presentations
- The ATP sensitive potassium channel (KATP) is a novel target for migraine drug development
- Clinical Conditions Targeted by OnabotulinumtoxinA in Different Ways in Medicine
- Hypertension: sex-related differences in drug treatment, prevalence and blood pressure control in primary care
- Research progress of post-acute sequelae after SARS-CoV-2 infection
- Novel Cosmetic Uses of Botulinum Toxin in the Head and Neck
- Therapeutic Potential of Gynostemma pentaphyllum Extract for Hair Health Enhancement: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial